Aileron Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$15,732,000 over the previous period. Total operating expenses were $16,276,000.
Profit Margin
| 2014 | 0 | -16.06M | |
|---|---|---|---|
| 2015 | 0 | -12.87M | |
| 2016 | 0 | -18.12M | |
| 2017 | 0 | -22.60M | |
| 2018 | 0 | -31.54M | |
| 2019 | 0 | -28.78M | |
| 2020 | 0 | -21.81M | |
| 2021 | 0 | -25.76M | |
| 2022 | 0 | -27.01M | |
| 2023 | 0 | -15.73M |
ALRN Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 119K | 169K | 121K | 163K | 155K | 0 | 95K | 0 | 325K | 9.33M |
Gross profit | -119K | -169K | -121K | -163K | -155K | 0 | -95K | 0 | -325K | -9.33M |
Operating exp. | ||||||||||
Research and development | 3.99M | 17.96M | 17.00M | 11.16M | 17.66M | 18.44M | 14.23M | 10.27M | 7.83M | 9.33M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 16.27M | 27.64M | 26.60M | 20.49M | 29.95M | 31.90M | 23.00M | 18.16M | 12.89M | 6.70M |
Operating income | -16.27M | -27.64M | -26.60M | -20.49M | -29.95M | -31.90M | -23.00M | -18.16M | -12.89M | -16.03M |
Other income (expenses), net | 544K | 318K | 400K | -661K | 587K | 355K | 404K | 46K | 13K | 9.99K |
Income before tax | -15.73M | -27.32M | -26.20M | -21.15M | -29.36M | -31.54M | -22.60M | -18.12M | -12.87M | -16.02M |
Income tax expense | 0 | -318K | -441K | 661K | -587K | 355K | 34K | 0 | 0 | 43K |
Net income | -15.73M | -27.01M | -25.76M | -21.81M | -28.78M | -31.54M | -22.60M | -18.12M | -12.87M | -16.06M |
Earnings per share | ||||||||||
Basic EPS | -3.42 | -5.95 | -5.8 | -12.52 | -23.46 | -42.81 | -60.74 | -33.21 | -23.6 | -845.63 |
Diluted EPS | -3.42 | -5.95 | -5.8 | -12.52 | -23.46 | -42.81 | -60.74 | -33.21 | -23.6 | -844.96 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |